Γονιμοτητα & θεραπεια με Ι-131
NEW YORK (Reuters Health) - For women with thyroid cancer treated with
radioiodine-131, subsequent pregnancy is safe without adverse outcomes
for the offspring. That’s according to a report by two Greek
researchers, published in Fertility & Sterility online February 7.
Dr. Chrissa Sioka and Dr. Andreas Fotopoulos at the University Hospital
of Ioannina reviewed 54 published reports on the effects of I-131
therapy for thyroid cancer on female and male gonads, and pregnancy
outcomes. The authors note that differentiated thyroid cancer occurs
three times more frequently in women than in men. With maximal surgical
thyroid resection, I-131 ablative therapy and thyroid hormone
replacement, the overall 10-year survival is estimated at 85%. Most
female patients are of reproductive age and many wish to have children,
according to the review. “Overall, most studies have demonstrated that
apart from a possible slightly earlier menopausal age, post surgical
administration of I-131 for ablation of residual thyroid cancer remnants
(up to 3.7 GBq activity) resulted only in transient menstrual cycle
abnormalities lasting up to a year, but no permanent ovarian failure,”
the researchers found. Furthermore, I-131 therapy appears to have no
significant effects on fertility, birth weight, or congenital anomalies
in offspring. In men, I-131 also affects gonadal function. For example,
in one cohort of 87 male patients, “serum FSH was elevated post therapy
in 87.4% and remained elevated after 12 months of follow-up in 20.7%.
Reduced sperm count was found in 35.8% of patients, which persisted
during the 12-month follow-up period in 13.2% of them.” However, another
study of 122 men treated with I-131 and followed for 21 years showed
that 59 of these patients fathered a total of 106 children. Summing up,
Drs. Sioka, and Fotopoulos, say I-131 therapy is associated with
transient amenorrhea or menstrual irregularities which usually resolve
within 1 year and impairment of spermatogenesis which is reversed within
18 months. “No effects of I-131 in fathers or mothers on subsequent
pregnancy outcomes and offspring have been documented.” They add that
most authorities recommend waiting a year after I-131 therapy before
attempting pregnancy, “to allow enough time for complete replacement of
irradiated spermatozoa and reversal of transient ovarian damage.”
http://www.thedoctorschannel.com/video/4084.html
Ημερομηνία δημοσίευσης: Παρασκευή 01 Απριλίου 2011 από
Διαχειριστή
|